News Categories
Resources For Living
Mesothelioma Forum
Legal Help Blog
Find a Doctor Near You
Mesothelioma Blog
Latest News
- Mesothelioma Patient Featured on ABC’s BostonMed
- Stand Up 2 Cancer Telethon Scheduled for September 10th – Tune In to Join the Cause to Raise Funds for Mesothelioma and Other Cancers
- All Forms of Asbestos Shown to Cause Mesothelioma
- Mesothelin Finding Could Lead to Early Detection of Mesothelioma
- New York Attorney Calls for International Ban on Mesothelioma-Causing Asbestos
- Protein Can be Reliable for Diagnosing Malignant Mesothelioma
- Biomarker Successes Remain Elusive For Mesothelioma and Cancer Researchers
- Avastin May Not be Effective for Breast Cancer, But is Still an Option for Mesothelioma
- Options for Funding Mesothelioma Research
- Golf Outing to Raise Funds for Mesothelioma Research
Wednesday, March 3, 2010
The makers of Oncolyn, a plant-derived natural anticancer remedy, claim that taking the tablets “caused objective and subjective improvement of patients with different types of cancers,” including mesothelioma.
Mesothelioma is a rare form of cancer typically affecting the lining of the lungs. Primarily caused by exposure to airborne asbestos fibers, most cases of mesothelioma are diagnosed 30 years or more after exposure. The latency period can be as long as 50 years.
Often called “asbestos cancer,” mesothelioma is highly aggressive and is resistant to many standard cancer treatments. Currently there is no known cure for mesothelioma, and the average survival time varies from 4 – 18 months after diagnosis. With such a grim prognosis, looking for ways to live longer and to improve their quality of life, many patients are turning to alternative treatments, natural remedies, and holistic care.
A product derived from three edible plants and a unique immune enhancing botanical extract with anti-carcinogenic and antimutagenic functions, Oncolyn, is touted as helping to reduce and neutralize the toxicity of harmful agents, helping to enhance immune cellular function, enhancing energy and mood levels, and enhancing the protection of leukocytes and platelets.
The makers of Oncolyn studied the effect of Oncolyn with standard chemotherapeutic agents. They found that Oncolyn “causes reduction of tumor size, inhibited vascularity on the surface and in the periphery of implanted tumor fragment and other morphological changes such as karyopyknosis and karyorrhexis consistent with apoptosis.” Apoptosis causes cancer cells to die.
In one study published in Natural Products in Cancer Therapy from a September 2008 symposium, researchers stated that when Oncolyn was used in the treatment of one pleural mesothelioma patient full remission was achieved and ten years later the patient remained cancer free.
Oncolyn was developed by Dr. Arthur H.K. D’Jang of Sante International. Dr. D’Jang is a licensed physician (M.D.) and certified specialist by the American Boards of Pathology (Clinical Pathology & Anatomic Pathology) and Nuclear Medicine and has expertise in Infectious Diseases, Biochemistry and Immunology ( Ph.D.,) Preventive Medicine ( M.P.H.) and Cytopathology.
Oncolyn is produced by Sante International. The drug is not FDA-approved, however, it does hold a U.S. patent.
© MesotheliomaHelp.Net. All Rights Reserved. Reprinting or republication of this article or any portion of its content is permitted but must include the MesotheliomaHelp.Net link.
Labels: mesothelioma, treatments
posted by Nancy Meredith at 7:44 AM
